Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice

PLoS ONE - United States
doi 10.1371/journal.pone.0148255
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Prolonged Activity of Factor IX as a Monomeric Fc Fusion Protein

Blood
BiochemistryImmunologyCell BiologyHematology
2010English

Comparative Field Study: Impact of Laboratory Assay Variability on the Assessment of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Activity

Thrombosis and Haemostasis
Hematology
2014English

A Single Chain Variant of Factor VIII Fc Fusion Protein Retains Normal in Vivo Efficacy but Exhibits Altered in Vitro Activity

PLoS ONE
Multidisciplinary
2014English

Evaluation of the Toxicology and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein in Animals

Thrombosis Research
Hematology
2015English

Indirect Comparison of the Efficacy of Recombinant Factor Viii Fc Fusion Protein and Other Factor Viii Products for ProphylaxisModeling the Effect of Compliance

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Oral Delivery of Bioencapsulated Coagulation Factor IX Prevents Inhibitor Formation and Fatal Anaphylaxis in Hemophilia B Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Performance of a Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin in One-Stage Clotting Assays

Journal of Thrombosis and Haemostasis
MedicineHematology
2018English

Prophylactic Efficacy of BeneFIX vs Alprolix in Hemophilia B Mice

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Molecular Basis of Hemophilia B: Identification of the Defect in Factor Ix Vancouver

1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy